Active, not recruitingPhase 3NCT06351020

LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
LaNova Medicines Zhejiang Co., Ltd.
Principal Investigator
Chunmei Bai
Peking Union Medical College Hospital
Intervention
LM-302(drug)
Enrollment
387 enrolled
Eligibility
18-80 years · All sexes
Timeline
20242026

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06351020 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials